NO953770L - Analysemetode - Google Patents

Analysemetode

Info

Publication number
NO953770L
NO953770L NO953770A NO953770A NO953770L NO 953770 L NO953770 L NO 953770L NO 953770 A NO953770 A NO 953770A NO 953770 A NO953770 A NO 953770A NO 953770 L NO953770 L NO 953770L
Authority
NO
Norway
Prior art keywords
analysis method
platelets
sample
concentration
measurement
Prior art date
Application number
NO953770A
Other languages
English (en)
Other versions
NO953770D0 (no
Inventor
Nils Olav Solum
Frank Brosstad
Paal Andre Holme
Geir Olav Gogstad
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO953770(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of NO953770D0 publication Critical patent/NO953770D0/no
Publication of NO953770L publication Critical patent/NO953770L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicinal Preparation (AREA)
  • Telephone Function (AREA)

Abstract

Metode for diagnostisering av hemostase-sykdommer hos menneske eller dyr basert på måling, i en prøve av kroppsvæske, av nærvær og/eller konsentrasjon av mikrovesikler avledet fra blodplater.
NO953770A 1993-03-24 1995-09-22 Analysemetode NO953770L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306053A GB9306053D0 (en) 1993-03-24 1993-03-24 Method and assay
PCT/GB1994/000592 WO1994022018A1 (en) 1993-03-24 1994-03-23 Method and assay

Publications (2)

Publication Number Publication Date
NO953770D0 NO953770D0 (no) 1995-09-22
NO953770L true NO953770L (no) 1995-09-22

Family

ID=10732620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953770A NO953770L (no) 1993-03-24 1995-09-22 Analysemetode

Country Status (13)

Country Link
US (1) US5811250A (no)
EP (1) EP0694168B2 (no)
JP (1) JP3422491B2 (no)
AT (1) ATE154847T1 (no)
AU (1) AU691489B2 (no)
CA (1) CA2158363C (no)
DE (1) DE69403961T3 (no)
DK (1) DK0694168T4 (no)
ES (1) ES2103582T5 (no)
FI (1) FI113206B (no)
GB (1) GB9306053D0 (no)
NO (1) NO953770L (no)
WO (1) WO1994022018A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
NO20031431D0 (no) * 2003-03-28 2003-03-28 Forskningsparken As Metode for å diagnostisere hemostatiske forstyrrelser ved bruk av mikrovesikler fra blodplater
US9372190B2 (en) * 2004-05-26 2016-06-21 Region Nordjylland Method of evaluation of the relative risk of developing atherosclerosis in patients
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2006088976A2 (en) * 2005-02-16 2006-08-24 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
DK2069528T3 (da) * 2007-02-05 2013-05-21 Region Nordjylland Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36
US20090104649A1 (en) * 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
ES2936256T3 (es) * 2008-02-01 2023-03-15 Massachusetts Gen Hospital Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas
IT1398680B1 (it) * 2009-06-12 2013-03-08 Bios Internat S R L Metodo in vitro per la determinazione della proteina gp91phox come marker di stress ossidativo
WO2011031892A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011031877A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
WO2011063324A2 (en) * 2009-11-20 2011-05-26 The General Hospital Corporation Microfluidic systems for isolating microvesicles
JP5753541B2 (ja) 2009-12-21 2015-07-22 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 抗ｖｅｇｆ治療によって治療された患者におけるタンパク尿の初期マーカー
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2638057B1 (en) 2010-11-10 2019-03-06 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities

Also Published As

Publication number Publication date
EP0694168B2 (en) 2002-06-12
JP3422491B2 (ja) 2003-06-30
ATE154847T1 (de) 1997-07-15
DE69403961D1 (de) 1997-07-31
EP0694168B1 (en) 1997-06-25
CA2158363A1 (en) 1994-09-29
CA2158363C (en) 2004-08-17
NO953770D0 (no) 1995-09-22
US5811250A (en) 1998-09-22
DE69403961T2 (de) 1998-01-02
AU691489B2 (en) 1998-05-21
WO1994022018A1 (en) 1994-09-29
DK0694168T3 (da) 1997-07-21
EP0694168A1 (en) 1996-01-31
GB9306053D0 (en) 1993-05-12
FI954499L (fi) 1995-09-22
DK0694168T4 (da) 2002-09-30
ES2103582T5 (es) 2002-12-16
FI113206B (fi) 2004-03-15
JPH08509806A (ja) 1996-10-15
ES2103582T3 (es) 1997-09-16
DE69403961T3 (de) 2003-01-16
FI954499A0 (fi) 1995-09-22
AU6262794A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
CA2332112A1 (en) Monitoring of physiological analytes
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
NO904001L (no) Fremgangsmaate og apparat, for diagnostisk analyse.
EA200600452A1 (ru) Автоматизированные способы и системы для обнаружения и анализа сосудистых бляшек
DK0638127T3 (da) Testartikel og fremgangsmåde til at udføre blodkoagulationsanalyser
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
ATE111228T1 (de) Verfahren zur überwachung des kollagenabbaus.
DE69910007D1 (de) Vorrichtung zum vorhersagen von physiologischen messwerten
NO922149D0 (no) Fremgangsmaater for paavisning av collagen-nedbrytning in vivo
DK0429612T3 (da) Fremgangsmåde til optisk analyse
DE68917399D1 (de) Testvorrichtung und Verfahren zur Protein-Untersuchung.
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
DE59914830D1 (de) Verfahren und testbesteck zur beurteilung der oxid messung ihrer antiradikalen aktivität
DK492185A (da) Screeningtest for omvendt-transkriptaseholdig virus
ES2103582T3 (es) Ensayo y kit.
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
ES2179081T3 (es) Procedimiento para la deteccion de perturbaciones del sistema de proteina c/proteina s.
SE9403833D0 (sv) Analysförfarande och kit
DE69209063D1 (de) Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
DE59710505D1 (de) Verwendung von tiefgefrorenem Blut für biologische Untersuchungsverfahren
SE0102896D0 (sv) System and method for blood analysis
DK70488D0 (da) Fremgangsmaade til paavisning af antistoffer i blod, samt membran og test-saet til anvendelse ved udoevelse af fremgangsmaaden
DK0745221T3 (da) Pyridinolin krydsbindinger som markører for periodontal og peri-implantat og sygdomsaktivitet
EP1666612A3 (fr) Procédé de détermination de l'activité d'une substance mettant en oeuvre un test fonctionnel in vitro